Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 11:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Smoking Cessation Intervention, Pain, Smoking (Tobacco) Addiction
Interventions: Smoking Cessation; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Spermatogenesis, Erectile Dysfunction
Interventions: Placebo, Udenafil; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 25 Years to 64 Years · Male only
Enrollment: 239 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 23
States / cities: Huntsville, Alabama • Anaheim, California • San Diego, California + 19 more

Conditions: Gastrointestinal Cancer
Interventions: Standard of Care, Rocking Chair Motion, Questionnaire; Procedure · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: BRCA1 Mutation, Breast Cancer, Breast Diseases, Breast Neoplasms, Breast Carcinoma, Neoplasms
Interventions: Denosumab, Placebo, Quality-of-Life Assessment; Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 25 Years to 55 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2033
U.S. locations: 47
States / cities: Los Angeles, California • San Francisco, California • Aurora, Colorado + 38 more

Conditions: Fasting
Interventions: Dinner, Fasting, Study food; Other
Lead sponsor: L-Nutra Inc; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Genito-Pelvic Pain/Penetration Disorder, Dyspareunia, Vaginismus, Pelvic Pain, Vestibulodynia, Vulvodynia (Chronic Vulvar Pain)
Interventions: Pelvic floor therapy; Device
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Depressive Symptoms, Stress, Psychological, Stress, Physiological
Interventions: mindfulness; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Opioid Withdrawal, Opioid Use Disorder
Interventions: EmbracePlus Smartwatch, Corti Sensor; Device
Lead sponsor: Spark Biomedical, Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 20 participants
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Center City, Minnesota • Columbus, Ohio

Conditions: Sexual Dysfunction, Physiological
Interventions: Testosterone Cream, Estring; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obesity
Interventions: Not listed
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 20 Years to 35 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2030
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Congenital Heart Disease in Children, Vital Signs, Pediatrics, Remote Monitoring
Interventions: Gabi SmartCare Pediarity System [Gabi Band, Gabi Monitor App, Gabi Analytics]; Device
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: Up to 2 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Reproductive Physiological Processes, Pediatrics, Adolescent Health, Adolescent Development
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 8 Years to 65 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2029
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Erectile Dysfunction, Sexual Dysfunction
Interventions: Natesto Nasal Product, Placebo; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 64 Years · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Clinical Alarms
Interventions: Alarm Advisor Software; Device
Lead sponsor: Philips Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 1,336 participants
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Eosinophilic Esophagitis
Interventions: CC-93538, Placebo; Drug · Other
Lead sponsor: Celgene; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 430 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 115
States / cities: Birmingham, Alabama • Tuscaloosa, Alabama • Phoenix, Arizona + 97 more

Conditions: Genitourinary System; Disorder, Female, Burning Vagina, Dyspareunia, Irritation; Vagina, Menopause Related Conditions, Urinary Incontinence, Urinary Bladder, Overactive, Urinary Tract Infections, Stress Urinary Incontinence
Interventions: fCO2 Laser Therapy Group; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Depression, Unipolar
Interventions: Intravenous Ketamine; Drug
Lead sponsor: Jay Fournier; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Endometriosis, Dysmenorrhea, Dyspareunia
Interventions: Norethindrone Acetate (NA), GnRH Agonist (Lupron Depot); Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Chronotropic Incompetence
Interventions: Pacemaker sensor set to MV, Pacemaker sensor set to XL; Device
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Albany, New York

Conditions: Chronic Prostatitis (CP), Chronic Pelvic Pain Syndrome (CPPS), Painful Bladder Syndrome (PBS), Benign Frequency Syndrome (BFS), Interstitial Cystitis
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: Non-hyperemic pressure ratio assessment pre and post PCI; Diagnostic Test
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stress, Stress, Psychological, Stress, Physiological, Stress, Emotional, Stress Reaction
Interventions: Education Program, Think Well Program, Be Well Program, Eat Well Program, Sleep Well Program, Move Well Program; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 712 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Erectile Dysfunction
Interventions: avanafil and enalapril, avanafil and amlodipine; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 40 Years to 65 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Vaginal Atrophy, Sexual Dysfunction, Vaginal Dryness, Dyspareunia
Interventions: Hybrid Fractional Laser; Device
Lead sponsor: Sciton; Industry
Eligibility: 40 Years to 70 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Miami, Florida

Search by objective public record fields.

Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain

Effect of Udenafil on Spermatogenesis

Rocking Motion: Physiologic Effect on the Surgical Stress Response

Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation

Effects of Fast Bar on Physiological Fasting

VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia

Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Adults in a FQHC

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients

Dietary, Physiological, Genetic, and Behavioral Predictors of Health in a Young, Ethnically-Mixed Population

WIReD: Wireless Interstage Remote Device Study

Reproductive Axis Maturation in the Early Post-Menarchal Years

Natesto Testosterone Nasal Gel for Hypogonadal Men

Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (USA)

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Laser Therapy for Treatment of Urogenital Symptoms in Women

Repeated Neurocognitive Measurements in Depressed Patients

Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)

Comparison of Physiologic Response With Rate Adaptive Pacing Driven by Minute Ventilation and Accelerometer

Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

Stress & Resilience Study

Drug Interaction Study of Avanafil and Enalapril or Amlodipine

Randomized, Controlled Trial With Hybrid Fractional Laser